At its first meeting under the new administration, the US Centers for Disease Control and Prevention’s (CDC) Advisory ...

The rest of the 23 CWD-positive deer harvested by hunters during the 2024-25 hunting season were found in Allen, Hardin, ...

US hospital data from 2018 through 2022 shows carbapenem-resistant Acinetobacter baumanii accounted for more than one third of all Acinetobacter nfections.

Pfizer's Abrysvo and GSK's Arexvy both received FDA-approval b in 2024 to include immunization of adults aged 50 to 59 years at increased risk for RSV disease.

The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to Pfizer’s respiratory syncytial virus vaccine Abrysvo for high-risk adults in ...

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

On Wednesday, the Advisory Committee on Immunization Practices (ACIP) voted to expand its recommendation for the use of ...

The Advisory Committee on Immunization Practices voted Wednesday to recommend lowering the age at which adults can get a ...

Pfizer (NYSE:PFE) recently received a CDC recommendation for wider use of its RSV vaccine, ABRYSVO, in adults aged 50-59 at ...

A year after narrowing its recommendation for who should use vaccines to defend against respiratory syncytial virus (RSV), a ...

Furthering its goal to grow the reach of its mRNA vaccines and guard against future pandemics, Moderna cleared a key ...

The Trump administration is considering eliminating dozens of programs at HHS amid a mass reorganization of the agency.